The mixed return on global ambition: are biotechs under-prepared for the dynamic international regulatory climate as they execute their commercialisation plans?
Arriello’s Sam Tomlinson reviews the findings of new US/EU research charting biotech efforts to expand their market globally. The biotech market was estimated to be…